Search This Blog

Monday, May 22, 2023

Northland Initiates Cardio Diagnostics at Outperform, 8 Price Target

 On May 22, 2023, Northland Capital Markets analyst, Carl Byrnes, made an announcement regarding Cardio Diagnostics Holdings (NASDAQ: CDIO). Byrnes initiated coverage on the company with an Outperform rating and a price target of $8. This target indicates a potential upside of 463.38% from the current stock price

https://beststocks.com/northland-capital-markets-analyst-initiates-c-2/

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.